Kidney Medullary Carcinoma

• CLINICAL_TRIALS trial_result · 2026-08-20
  Clinical Trial Results: Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma [Phase 2]

  Phase II trial evaluating nivolumab plus ipilimumab in renal medullary carcinoma shows results and has been terminated.

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study [Phase 2]

  Phase 2 trial exploring the addition of radium-223 dichloride to cabozantinib for advanced renal cell carcinoma with bone metastases (RadiCa…

• CLINICAL_TRIALS trial_result · 2026-04-13
  Clinical Trial Update: Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors [Phase 1, Phase 2]

  Clinical trial update of a tiragolumab plus atezolizumab combination for relapsed or refractory SMARCB1/SMARCA4-deficient tumors, spanning P…

• CLINICAL_TRIALS research · 2025-03-25
  Clinical Trial Update: Study of Kidney Tumors in Younger Patients

  The Children's Oncology Group study of kidney tumors in younger patients is currently active but not recruiting. It covers multiple pediatri…